This page requires JavaScript. Please enable it in your browser settings.
GenomePaint paper
User tutorial
Data release
Figure 2:
Visualizing common or rare regulatory variants in T-ALL samples on Cohort View.
Figure 3:
Sample View of interchromsomal rearrangement leading to
MYC
dysregulation by enhancer hijacking.
Figure 4:
Assessing aberrant splicing in
CREBBP
caused by somatic splice site variants.
Figure 5:
MYC
dysregulation by enhancer duplications in pediatric cancers.
Figure 7:
Visualizing intratumor heterogeneity of TCGA GBM at
EGFR
locus.
Online example 1:
TP53
bi-allelic loss in adrenocortical tumors.
Online example 2:
IKZF1
haploinsufficiency in B-ALL.
Online example 3:
MYB
alteration status in T-ALL and the association with patient outcome.
Online example 4:
Association of
MDM2
expression in AML with patient outcome.
Online example 5:
Matrix View of mutual-exclusive or co-mutation patterns and association with patient outcome.
Online example 6:
A
TP53
splice site mutation causing intron retention inspected via Sample View.
Online example 7:
APOBEC signature is associated with kataegis as revealed by rainfall plot in Sample View.
Online example 8:
TCGA DLBC cohort mutation profile over
CDKN2A/B
locus.
Online example 9:
TCGA SKCM cohort mutation profile over
TERT
.
Supplementary figure 2:
Diverse alterations in B-ALL targeting
CREBBP
RING domain.
Supplementary figure 3:
CNV and chromatin interactions over
MYC
and its enhancers.
Supplementary figure 4:
DUX4 but not NOTCH1 likely binds at N-ME in NALM6.
Supplementary figure 5:
In
EGFR
-amplified GBM, clonality of oncogenic coding mutations can vary with the presence or absence of the vIII isoform.
Supplementary figure 6:
Illustrating the
EGFR
exon 8 ITD event along with the reinterpretation of a sequence mutation.